|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sparse registration for three-dimensional stress echocardiography显示文摘 | Esther K Y and Van M | 2008 | IEEE Transactions on Medical Imaging2008，27，11： | 1 |
| 2 | Differential association of oral and transder?mal oestrogen replacement therapy with venous thromboem?bolism risk显示文摘 | Scarabin P Y Oger E Plu -Bureau G (for the ESTHER Study Group) | 2003 | Lancet2003，362，9382： | 1 |
| 3 | Innovation strategy and performance during economic transition:evidences in Beijing显示文摘 | Guan J C Richard c M Esther P Y | 2009 | China Research Policy2009，2，38： | 1 |
| 4 | Shareholder heterogeneity and conflicting goals: Strategic investments in the Japanese electronics industry 显示文摘 | Asli M C Torn Y Takashi H Esther B Del B | 2011 | Journal of Management Studies2011，48，3： | 1 |
| 5 | An audit of technological innovation capabilities in Chinese firms: some empirical findings in Beijing, China 显示文摘 | Richard C M Y Jian Cheng Guan Kit Fai Pun Esther P Y T | 2004 | Research Policy2004，33，8： | 1 |
| 6 | Fibroblast growth factor-2 inhibit endothelial cell apoptosis by bcl-2-dependent and independent mechanisms显示文摘 | Aly K Esther Y Guy G P | 1997 | Amer J Pathol1997，151，6： | 1 |
| 7 | An audit of technological innovation capabilities in Chinese firms: Some empirical findings in Beijing, China显示文摘 | Yam R M Esther W Tang P Y | 2004 | Re- search Policy2004，33，12： | 1 |
| 8 | Analysis of source of innovation,technological innovation capabilities,and performance:An empirical study of Hongkong manufacturing industries显示文摘 | Richard C.M William L Esther P Y Tang Antonio K W Law | 2010 | 2010，，40： | 1 |
| 9 | Analysis of sources of innovation,technological innovation capabilities,and performance:an empirical study of Hong Kong manufacturing industries显示文摘 | RICHARD C M Yam WILLIAM Lo ESTHER P Y Tang ANTONIO K W Lau | 2011 | Research policy2011，40，3： | 1 |
| 10 | Oogenesis in telelosts: How fish eggs are toumed 显示文摘 | ESTHER L GRAHAM Y JULIEN B | 2010 | General and comparative endocrinology2010，165，3： | 1 |
| 11 | Analysis of sources of innovation,technological innovation capabilities,and performance:an empirical study of Hong Kong manufacturing industries显示文摘 | Richard C M Yam William Lo Esther P Y Tang Antonio K W Lau | | 0，，03： | 1 |
| 12 | Analysis of innovation, technological innovation capa- bilities, and performance: An empirical study of Hong Kong manufacturing industries显示文摘 | Richard C of sources M William L Esther P Y | 2011 | Research Policy2011，40，3： | 1 |
| 13 | Current Research on Low Carbon Cities and Institutional Reponses显示文摘 | Edwin H W Lennon H T Esther H K Y | 2013 | Habitat International2013，37，1： | 1 |
| 14 | Exploring Teacher Job Satisfaction,across years of Teaching Experience显示文摘 | | 2001 | Christian Education Journal2001，，1： | 1 |
| 15 | Exploring Teacher Job Satisfaction, Across Years of Teaching Experience 显示文摘 | Esther Y | 2001 | Christian Education Journal2001，5，1： | 1 |
| 16 | Analysis of sources of innovation, technological innovation capabili- ties, and performance: An empirical study of Hong Kong manufacturing industries 显示文摘 | Richard C M Yam William Lo Esther P Y Tang | 2010 | Research Policy2010，40，3： | 1 |
| 17 | Crystal structure and magnetic behaviour of a five-coordinate iron(Ⅲ)complex of pyridoxal-4-methylthiosemicarbazone显示文摘 | EDDY W TIDO Y ESTHER J M | 2007 | Inorg Chim Acta2007，360，13： | 1 |
| 18 | 幽门螺杆菌治疗后长期使用质子泵抑制剂与胃癌发生的风险:以人群为基础的研究显示文摘目的质子泵抑制剂(PPIs)与胃萎缩恶化相关,尤其是在幽门螺杆菌(HP)感染者中。我们确定了在接受抗HP治疗的HP感染者中,PPIs使用与胃癌(GC)之间的相关性。设计本研究以中国香港全区健康资料库为基础。我们首先确认出自2003至2012年间接受过以克拉霉素为基础的三联疗法门诊处方的成年人。排除标准:使用该处方治疗失败的患者,HP治疗后12个月内确诊为GC的患者,以及治疗后发生胃溃疡者。GC排除前的6个月内开始PPIs或H2受体阻滞剂(H2RA)治疗,以避免原始偏倚。通过C。x比例风险模型的倾向分数调整,评估GC发生风险与质子泵抑制剂二者之间的关系。H2RA作为阴性对照暴露。结果共63 397名合格受试者入选,在平均7.6年的随访时间中,有153(0.24%)名发生GC。PPIs使用与GC发生风险增高相关[危害比(HR)2.44,95%可信区间(C/)1.42-4.20],而H2RA无相关性(“R 0.72,95%CI 0.48-1.07)0GC发生的风险随PPIs使用时间的延长而增高(PPIs使用时间/年22年和年的GC发生风险分别为:HR 5.04.95%CI 1.23-20.61;6.65,1.62-27.26和8.34,95%CI 2.02-34.41)。PPIs使用相比非PPIs使用,调整的绝对风险差为每10000人年超过4.29 GC(95%C/1.25-9.54)。结论即使在HP根除治疗后,长期使用质子泵抑制剂仍与GC的发生风险增加相关。 | Ka Shing Cheung Esther W Chan Angel Y S Wong Lijia Chen lan C K Wong Wai Keung Leung 彭浩(译) | 2019 | 英国医学杂志中文版2019，22，7： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员